Neuvivo, Inc.

New Filing
CIK: 0002154992·Pharmaceuticals·DELAWARE·Filed: Nov 13, 2026
Total Offering

$9,500,000

Amount Sold

$1,384,615

Investors

1

First Sale

Oct 30, 2026

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Michael McGrath
Related Person
Virit Vichitvadakan
Related Person
Pornsit Poovanakijjakorn
Related Person
Robert Baffi
Related Person
John Curnutte
Related Person

Company

Neuvivo, Inc.

2100 GENG ROAD

PALO ALTO, CA, 94303

(650) 440-6766

SEC Filing

0001104659-26-127191

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free